Stock listing
ALMS Stock Price, News, Filings & Events — Alumis Inc.
Selected listing: ALMS · NASDAQ · USD · US
This page tracks Alumis Inc.'s ALMS:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ALMS:NASDAQ. ALMS:NASDAQ is the stock-level entry point for investors researching Alumis Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Alumis Inc. (ticker: ALMS) is a public company operating in the American market. With a market capitalization of approximately $3.65 billion, Alumis focuses on delivering innovative solutions in its sector. The company is committed to growth and development, positioning itself as a key player in its industry.

- Ticker
- ALMS:NASDAQ
- Asset type
- Stock
- Market cap
- $3.23B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Alumis Inc. ALMS:NASDAQ stock context
This page tracks Alumis Inc.'s ALMS:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ALMS:NASDAQ. ALMS:NASDAQ is the stock-level entry point for investors researching Alumis Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Alumis Inc. (ticker: ALMS) is a public company operating in the American market. With a market capitalization of approximately $3.65 billion, Alumis focuses on delivering innovative solutions in its sector. The company is committed to growth and development, positioning itself as a key player in its industry.
Latest news from Alumis Inc.
Alumis Reports Second Quarter 2026 Financial Results and Highlights Recent Achievements
August 13, 2026
Envudeucitinib Long-term Data Positioned to Set a New Standard for Plaque Psoriasis Treatment, Delivering Highest Reported PASI 100 Skin ...
August 10, 2026
Alumis Reports First Quarter 2026 Financial Results and Highlights Recent Achievements
May 14, 2026
Alumis’ Envudeucitinib Delivers Early and Robust Improvements in Skin Clearance, Quality of Life and Psoriasis Symptoms in Two Phase 3 Tr...
March 28, 2026
Alumis Reports Year End 2025 Financial Results and Highlights Recent Achievements
March 19, 2026
Research Alumis Inc.
Alumis Inc. investor report
Review AI stock analysis and investor report context for ALMS:NASDAQ.
Alumis Inc. company profile
View the public company page for Alumis Inc. on 6ix.
Alumis Inc. news
Read company news and market updates connected to Alumis Inc..
Alumis Inc. investor events
Find investor webinars, events, and replay context for Alumis Inc..